Clin2
NCT07414810Likely a fitNot yet recruiting

Sweat test device for monitoring CF treatment

Cystic Fibrosis

Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.

This trial tests a new, simple device that measures sweat chloride (salt) levels at the doctor's office or even at home. The goal is to see how well this device works for monitoring how CF treatments are helping your body.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
2 weeks to 90 years
Study type
Interventional

Who can take part

  • You are between 0 and 90 years old.
  • You have a confirmed diagnosis of cystic fibrosis (CF) from a genetic test or newborn screen.
  • You do not have skin issues like eczema or psoriasis on your forearms that would prevent a sweat test.
  • You are willing to give written consent (or have a parent/guardian do so if you are a minor).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06504589Recruiting
Study for CF treatments for people without modulators

This study tests new treatments for cystic fibrosis in people who cannot take or choose not to take current CFTR modulators. It aims to find better options for managing CF.

Birmingham, Alabama
NCT03587961Recruiting· Early Phase 1
Personalized testing to find the best CF medicine for you

This early study tests an individualized approach (“theratyping”) to match your cystic fibrosis (CF) to the CFTR medicine that may work best for your specific genetic change. It may help find a more tailored treatment plan and see how your body responds, while using medicines that are already approved for some people with CF.

Birmingham, Alabama
NCT03161808Recruiting
CF rare mutation blood and tissue sample collection study

This study collects cells from people with cystic fibrosis (CF) caused by rare CFTR gene changes. The goal is to build a cell bank for future research, which may help scientists develop better tests and treatments for rare CF types.

Birmingham, Alabama
NCT06836453Recruiting
New sweat test for cystic fibrosis diagnosis

This trial tests a new device that measures how your sweat glands react to a common asthma medication. It aims to better classify people with cystic fibrosis or related diseases, and also includes healthy volunteers and carriers.

Brussels
NCT05998629Recruiting
Sweat sensor test for cystic fibrosis

This trial tests a new skin sensor that measures sweat to help diagnose cystic fibrosis. It compares results from people with CF and healthy volunteers to see if the device works accurately.

Hershey, Pennsylvania
NCT04580368Recruiting
Personalized drug testing for cystic fibrosis using small trials

This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.

Cincinnati, Ohio

Hear when a new Cystic Fibrosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.